Teva announced it will lay off 2,900 employees by 2027 - approximately 8% of its workforce, aiming to achieve an operating profit margin of 30%. The pharmaceutical company ended the first quarter of 2025 with revenues of $3.89 billion, slightly below forecasts of $4 billion. However, net profit excluding one-time and accounting items reached 52 cents per share compared to expected 48 cents per share. The quarterly revenues reflect a slow growth rate of only 5%.
Teva: 2,900 employees to be laid off by 2027 - about 8% of workforce
Sophie Shulman, Calcalist|
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.